Your browser is no longer supported. Please, upgrade your browser.
Settings
PCVX [NASD]
Vaxcyte, Inc.
Index- P/E- EPS (ttm)- Insider Own1.40% Shs Outstand50.90M Perf Week-5.00%
Market Cap1.27B Forward P/E- EPS next Y-2.58 Insider Trans-55.87% Shs Float41.43M Perf Month-22.64%
Income- PEG- EPS next Q-0.54 Inst Own85.40% Short Float6.62% Perf Quarter-47.30%
Sales- P/S- EPS this Y-70.50% Inst Trans-0.52% Short Ratio10.03 Perf Half Y-26.22%
Book/sh7.15 P/B3.46 EPS next Y59.20% ROA- Target Price- Perf Year-
Cash/sh7.75 P/C3.19 EPS next 5Y11.80% ROE- 52W Range17.80 - 58.47 Perf YTD-7.00%
Dividend- P/FCF- EPS past 5Y- ROI- 52W High-59.16% Beta-
Dividend %- Quick Ratio10.10 Sales past 5Y- Gross Margin- 52W Low34.16% ATR2.21
Employees43 Current Ratio10.10 Sales Q/Q- Oper. Margin- RSI (14)32.23 Volatility5.89% 7.76%
OptionableNo Debt/Eq0.00 EPS Q/Q85.70% Profit Margin- Rel Volume0.71 Prev Close24.71
ShortableYes LT Debt/Eq0.00 Earnings- Payout- Avg Volume273.33K Price23.88
Recom1.60 SMA20-12.42% SMA50-22.74% SMA200-35.49% Volume164,076 Change-3.36%
Jul-07-20Initiated Needham Buy $40
Jul-07-20Initiated Cantor Fitzgerald Overweight $55
Jul-07-20Initiated BofA Securities Buy $37
Jan-06-21 08:15AM  
Dec-22-20 08:00AM  
Dec-10-20 06:34PM  
Nov-24-20 04:05PM  
Nov-12-20 04:15PM  
Nov-10-20 04:41PM  
Sep-23-20 07:00AM  
Sep-14-20 02:27PM  
Sep-09-20 05:28PM  
Aug-14-20 03:01PM  
Aug-12-20 04:59PM  
04:10PM  
Jun-16-20 04:05PM  
Jun-12-20 11:24AM  
06:18AM  
01:06AM  
Jun-03-20 08:30AM  
May-21-20 08:30AM  
Vaxcyte, Inc., a preclinical-stage biotechnology vaccine company, develops vaccines to prevent or treat infectious diseases worldwide. Its lead vaccine candidate is VAX-24, a 24-valent investigational pneumococcal conjugate vaccine. The company also develops VAX-XP to protect against emerging strains causing significant invasive pneumococcal disease and antibiotic resistance; VAX-A1, a conjugate vaccine candidate for protection against subtypes of Group A Strep; and VAX-PG, a novel protein vaccine candidate targeting porphyromonas gingivalis. The company was formerly known as SutroVax, Inc. and changed its name to Vaxcyte, Inc. in May 2020. Vaxcyte, Inc. was founded in 2013 and is headquartered in Foster City, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Hopfner Robert LorneDirectorJan 19Sale25.6249,5161,268,6341,888,901Jan 19 09:07 PM
Wright-Mitchell JaneGeneral CounselJan 15Option Exercise2.032,5005,0754,062Jan 19 06:29 PM
Hopfner Robert LorneDirectorJan 15Sale25.7826,677687,8461,938,417Jan 19 09:07 PM
Wright-Mitchell JaneGeneral CounselJan 15Sale26.002,50065,0001,562Jan 19 06:29 PM
Hopfner Robert LorneDirectorJan 14Sale25.8814,918386,0781,965,094Jan 19 09:07 PM
Hopfner Robert LorneDirectorJan 13Sale25.9529,110755,3131,980,012Jan 13 08:39 PM
Hopfner Robert LorneDirectorJan 12Sale26.3818,567489,8712,009,122Jan 13 08:39 PM
Sauer PaulSVP Process Dev, ManufacturingJan 11Option Exercise1.792,5004,47580,399Jan 12 09:43 PM
Hopfner Robert LorneDirectorJan 11Sale26.4549,6661,313,7642,027,689Jan 13 08:39 PM
Sauer PaulSVP Process Dev, ManufacturingJan 11Sale26.212,50065,52777,899Jan 12 09:43 PM
Hopfner Robert LorneDirectorJan 08Sale26.5840,6121,079,5492,077,355Jan 08 05:17 PM
Hopfner Robert LorneDirectorJan 07Sale28.2747,5801,344,8872,117,967Jan 08 05:17 PM
Hopfner Robert LorneDirectorJan 06Sale29.5357,4201,695,8412,165,547Jan 08 05:17 PM
Fairman JeffVP, ResearchDec 29Option Exercise1.797401,3251,408Dec 30 08:26 PM
PICKERING GRANTPresident & CEODec 28Option Exercise1.795,5009,845578,691Dec 29 06:01 PM
PICKERING GRANTPresident & CEODec 21Option Exercise1.7915,00026,850588,191Dec 22 08:44 PM
PICKERING GRANTPresident & CEODec 21Sale28.8815,000433,141573,191Dec 22 08:44 PM
TPG Group Holdings (SBS) AdvisFormer 10% OwnerDec 15Sale32.5081,9792,664,6915,074,574Dec 17 07:13 PM
RA CAPITAL MANAGEMENT, L.P.10% OwnerOct 08Sale50.69167,6618,498,0655,001,593Oct 09 04:22 PM
RA CAPITAL MANAGEMENT, L.P.10% OwnerOct 07Sale50.9598,5975,023,5275,169,254Oct 09 04:22 PM
RA CAPITAL MANAGEMENT, L.P.10% OwnerSep 30Sale50.27124,6566,265,8715,283,818Oct 01 05:25 PM
RA CAPITAL MANAGEMENT, L.P.10% OwnerSep 29Sale52.0880,7074,202,9875,408,474Oct 01 05:25 PM